Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for SPC
Fordham 33 (Report 4): Life sciences and healthcare innovation Fordham 33 (Report 4): Life sciences and healthcare innovation Reviewed by Annsley Merelle Ward on Tuesday, April 14, 2026 Rating: 5
Veterinary versus human use under Article 3(d): CJEU asked to revisit Santen Veterinary versus human use under Article 3(d): CJEU asked to revisit Santen Reviewed by Dr Rose Hughes on Saturday, January 17, 2026 Rating: 5
UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 Reviewed by Annsley Merelle Ward on Friday, May 09, 2025 Rating: 5
Fordham 32 (Report 1): Patents in Pharma Fordham 32 (Report 1): Patents in Pharma Reviewed by Annsley Merelle Ward on Thursday, April 24, 2025 Rating: 5

Sunday Surprises

With rising temperatures and spring in the air in Europe, here come the latest Kat news, events and more. Kat news Eleonora Rosati commen...
- Sunday, March 17, 2024
Sunday Surprises Sunday Surprises Reviewed by Marcel Pemsel on Sunday, March 17, 2024 Rating: 5
UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471) UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471) Reviewed by Dr Rose Hughes on Monday, September 04, 2023 Rating: 5
Sweden gets into the Article 3 SPC referral game in AstraZeneca dapagliflozin case Sweden gets into the Article 3 SPC referral game in AstraZeneca dapagliflozin case Reviewed by Henry P Yang on Wednesday, March 01, 2023 Rating: 5
How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently Reviewed by Gabriele Girardello on Monday, November 14, 2022 Rating: 5
A new study on the options for a unified supplementary protection certificates (SPCs) system in Europe! A new study on the options for a unified supplementary protection certificates (SPCs) system in Europe! Reviewed by Frantzeska Papadopoulou on Monday, October 24, 2022 Rating: 5
After Michael Jordan: a new typical case on what is the right of likeness under the Civil Code of China After Michael Jordan: a new typical case on what is the right of likeness under the Civil Code of China Reviewed by Tian Lu on Saturday, June 04, 2022 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.